As Covid Drug Cash Dwindles, Vigonvita Targets New Remedies
A Chinese biotech that became popular by co-developing an anti-Covid drug has filed for a Hong Kong stock market listing.
Hosted on MSN1mon
Junshi partners LEO Pharma for toripalimab distribution in Europe
Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences are set to enter a collaboration with LEO Pharma to distribute and market the monoclonal antibody, toripalimab, in Europe.
Nasdaq1mon
Junshi Biosciences’ Toripalimab Gains Regular Approval for Melanoma Treatment
Shanghai Junshi Biosciences Co., Ltd. announced that its drug toripalimab has received regular approval from the National Medical Products Administration for the treatment of unresectable or ...
Business Insider1mon
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to ...
Morningstar1mon
Junshi Biosciences Announces Toripalimab’s Approval in Australia
SHANGHAI, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to ...
American Association of Individual Investors26d
Why Coherus BioSciences, Inc.’s (CHRS) Stock Is Up 10.66%
Coherus BioSciences, Inc.’s CHRS share price has surged by 10.66%, which has investors questioning if this is right time to ...
Nasdaq1mon
Shanghai Junshi’s JS212 Drug Application Accepted, Boosting Cancer Therapy Pipeline
Shanghai Junshi Biosciences Co., Ltd. announced that its investigational new drug application for JS212 injection has been accepted by the National Medical Products Administration. JS212 is a ...
Yahoo Finance7d
Shanghai Junshi Biosciences Co., Ltd. (688180.SS)
SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
manilatimes1mon
Junshi Biosciences Announces Toripalimab's Approval in Australia
SHANGHAI, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...